5.38 - 5.60
4.95 - 8.28
2.3K / 2.4K (Avg.)
-279.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-2.92%
Negative revenue growth while VALMT.HE stands at 23.31%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
0.85%
Gross profit growth under 50% of VALMT.HE's 22.00%. Michael Burry would be concerned about a severe competitive disadvantage.
5.50%
EBIT growth below 50% of VALMT.HE's 147.37%. Michael Burry would suspect deeper competitive or cost structure issues.
5.50%
Operating income growth under 50% of VALMT.HE's 147.37%. Michael Burry would be concerned about deeper cost or sales issues.
-2.93%
Negative net income growth while VALMT.HE stands at 158.33%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-14.29%
Negative EPS growth while VALMT.HE is at 162.50%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-14.29%
Negative diluted EPS growth while VALMT.HE is at 162.50%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
13.25%
Slight or no buybacks while VALMT.HE is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
13.25%
Diluted share change of 13.25% while VALMT.HE is zero. Bruce Berkowitz might see a minor difference that could widen over time.
No Data
No Data available this quarter, please select a different quarter.
0.45%
OCF growth under 50% of VALMT.HE's 1000.00%. Michael Burry might suspect questionable revenue recognition or rising costs.
5.36%
FCF growth under 50% of VALMT.HE's 287.50%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
-38.04%
Negative 10Y revenue/share CAGR while VALMT.HE stands at 52.56%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-42.49%
Negative 5Y CAGR while VALMT.HE stands at 52.56%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-36.19%
Negative 3Y CAGR while VALMT.HE stands at 52.56%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
4.86%
10Y OCF/share CAGR under 50% of VALMT.HE's 472.58%. Michael Burry would worry about a persistent underperformance in cash creation.
-217.21%
Negative 5Y OCF/share CAGR while VALMT.HE is at 472.58%. Joel Greenblatt would question the firm’s operational model or cost structure.
-355.17%
Negative 3Y OCF/share CAGR while VALMT.HE stands at 472.58%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
120.93%
Below 50% of VALMT.HE's 2000.00%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
135.29%
Below 50% of VALMT.HE's 2000.00%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-0.00%
Negative 3Y CAGR while VALMT.HE is 2000.00%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
-6.29%
Negative 5Y equity/share growth while VALMT.HE is at 34.68%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-6.77%
Negative 3Y equity/share growth while VALMT.HE is at 34.68%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
132.59%
3Y dividend/share CAGR of 132.59% while VALMT.HE is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-7.18%
Firm’s AR is declining while VALMT.HE shows 0.00%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
6.31%
We show growth while VALMT.HE is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
-4.84%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-10.52%
We have a declining book value while VALMT.HE shows 5.27%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
1.15%
We have some new debt while VALMT.HE reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
No Data
No Data available this quarter, please select a different quarter.
-4.74%
We cut SG&A while VALMT.HE invests at 2.31%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.